ITGDF (Integral Diagnostics) Beginning Cash Position: $34.6 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ITGDF Integral Diagnostics Ltd ITGDF
72 GF Score
Price $2.61
GF Value $1.17
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Integral Diagnostics Beginning Cash Position?

Integral Diagnostics ITGDF 72 Beginning Cash Position is $34.6 Mil as of Dec. 2025. GuruFocus rates ITGDF with a GF Score™ of 72/100 and a GF Value™ of $1.17 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Integral Diagnostics's Beginning Cash Position for the quarter that ended in Dec. 2025 was $34.6 Mil.

Integral Diagnostics's quarterly Beginning Cash Position declined from Dec. 2024 ($26.9 Mil) to Jun. 2025 ($20.4 Mil) but then increased from Jun. 2025 ($20.4 Mil) to Dec. 2025 ($34.6 Mil).

Integral Diagnostics's annual Beginning Cash Position declined from Jun. 2023 ($82.7 Mil) to Jun. 2024 ($22.5 Mil) but then increased from Jun. 2024 ($22.5 Mil) to Jun. 2025 ($27.6 Mil).

Integral Diagnostics Beginning Cash Position Related Terms

Integral Diagnostics Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Integral Diagnostics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integral Diagnostics Beginning Cash Position Chart

Integral Diagnostics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.32 43.71 82.68 22.48 27.63

Integral Diagnostics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.66 11.94 26.88 20.36 34.62
ITGDF
72GF Score
Integral Diagnostics Ltd ITGDF
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integral Diagnostics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $34.6 Mil mean?
Integral Diagnostics (ITGDF) has a Beginning Cash Position of $34.6 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Integral Diagnostics and its competitors.
Is Integral Diagnostics' Beginning Cash Position too high?
Integral Diagnostics' current Beginning Cash Position is $34.6 Mil. Overall, Integral Diagnostics has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Integral Diagnostics' Beginning Cash Position compare to TMO and DHR?
Integral Diagnostics' Beginning Cash Position of $34.6 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Diagnostics & Research company?
A good Beginning Cash Position depends on the Medical Diagnostics & Research industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Integral Diagnostics and its competitors. Integral Diagnostics's current Beginning Cash Position is $34.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integral Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Integral Diagnostics (ITGDF) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.17, compared to a current price of $2.61 — trading 123.3% above its estimated fair value. The current Beginning Cash Position is $34.6 Mil. Integral Diagnostics' overall GF Score™ is 72/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Integral Diagnostics (ITGDF), the current Beginning Cash Position is $34.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integral Diagnostics (ITGDF) Overvalued in 2026?

Based on GuruFocus' analysis, Integral Diagnostics stock appears to be overvalued. The current stock price of $2.61 is trading 123.3% above its estimated GF Value™ of $1.17. GuruFocus considers Integral Diagnostics to be Significantly Overvalued.

Key valuation signals for ITGDF:

  • Beginning Cash Position: $34.6 Mil
  • GF Value™: $1.17 vs. price of $2.61 (123.3% above fair value)
  • GF Score™: 72/100 with 9 warning signs

No single metric tells the full story. See the ITGDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Integral Diagnostics Business Description

Other Exchanges IDX:Australia
Address 288 Victoria Parade, Level 2, Melbourne, VIC, AUS, 3002
Integral Diagnostics is a major Australian diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.
72GF Score

Get the complete analysis for ITGDF

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.61
Price
$1.17
GF Value